+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

Biosimilar Therapeutic Peptides Global Market Report 2024 - Product Thumbnail Image

Biosimilar Therapeutic Peptides Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Glioma Treatment Global Market Report 2024 - Product Thumbnail Image

Glioma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Drugs For Benign Prostatic hypertrophy Global Market Report 2024 - Product Thumbnail Image

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Company Snapshots: France Pharmaceutical - Product Thumbnail Image

Company Snapshots: France Pharmaceutical

  • Newsletter
  • November 2024
  • 35 Pages
  • France
From
Chronic Disease Markets for Sustained Released Injectables - Product Thumbnail Image

Chronic Disease Markets for Sustained Released Injectables

  • Report
  • December 2023
  • 217 Pages
  • Global
From
From
Follicular Lymphoma Treatment Global Market Report 2024 - Product Thumbnail Image

Follicular Lymphoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Extended Release Injectable Drugs - Product Thumbnail Image

Extended Release Injectable Drugs

  • Report
  • June 2023
  • 200 Pages
  • Global
From
From
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Industry Snapshots: France Pharmaceutical - Product Thumbnail Image

Industry Snapshots: France Pharmaceutical

  • Newsletter
  • November 2024
  • 50 Pages
  • France
From
BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028 - Product Thumbnail Image

BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
Loading Indicator